MindRank Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$52M
- Investors
-
9
MindRank General Information
Description
Developer of an AI-powered drug discovery platform designed to accelerate the identification and optimization of novel small-molecule therapeutics. The company's platform integrates deep learning, generative AI, and protein simulation to enable end-to-end molecular design for hard-to-drug targets, enabling pharmaceutical companies to reduce development timelines and costs by approximately 60% while advancing a proprietary pipeline including an oral GLP-1 receptor agonist for obesity currently in Phase III clinical trials.
Contact Information
Website
www.mindrank.aiCorporate Office
- Room 1901-1914, 19th Floor, Building 2
- Number 2 Kejiyuan Road, Baiyang Street, Qiantang District
- Hangzhou, Zhejiang 310018
- China
Corporate Office
- Room 1901-1914, 19th Floor, Building 2
- Number 2 Kejiyuan Road, Baiyang Street, Qiantang District
- Hangzhou, Zhejiang 310018
- China
MindRank Timeline
MindRank Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 08-Jul-2026 | $52M | Completed | Generating Revenue | ||
| 7. Early Stage VC | 11-Aug-2025 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jul-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A1) | 13-Jul-2023 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 14-Mar-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 16-Dec-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 21-May-2021 | $6.96M | $6.96M | Completed | Startup | |
| 1. Secondary Transaction - Private | 10-May-2021 | Completed | Startup |
MindRank Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MindRank Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MindRank Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shenyin & Wanguo Investment | PE/Buyout | Minority | ||
| Star River Group | Corporation | Minority | ||
| Cherami Investment Group | Asset Manager | Minority | ||
| Jingjie Investment | Corporate Venture Capital | Minority | ||
| Green Pine Capital Partners | Venture Capital | Minority |
MindRank FAQs
-
When was MindRank founded?
MindRank was founded in 2020.
-
Where is MindRank headquartered?
MindRank is headquartered in Hangzhou, China.
-
What is the size of MindRank?
MindRank has 40 total employees.
-
What industry is MindRank in?
MindRank’s primary industry is Drug Discovery.
-
Is MindRank a private or public company?
MindRank is a Private company.
-
What is MindRank’s current revenue?
The current revenue for MindRank is .
-
How much funding has MindRank raised over time?
MindRank has raised $82M.
-
Who are MindRank’s investors?
Shenyin & Wanguo Investment, Star River Group, Cherami Investment Group, Jingjie Investment, and Green Pine Capital Partners are 5 of 9 investors who have invested in MindRank.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
